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Abstract 
Type 1 diabetes mellitus (T1DM) is a common chronic disease in childhood. Fifty percent of subjects with 
T1DM are diagnosed within the first 15 years of life. Continuous Subcutaneous Insulin Infusion (CSII) and 
Multiple Daily insulin Injections (MDI) are both strategies aiming to achieve a tight glycemic and metabolic 
control. However, the choice between them remains controversial. The aim of the present study was to compare 
between continuous subcutaneous insulin infusion and multiple daily insulin injections and assess its effects on 
quality of life among children with type 1 diabetes. A comparative randomized design was conducted at maternal 
and children's hospital in Sakaka city of Aljouf area. Twenty five children with type 1 diabetes mellitus on CSII 
and 25 children on MDI were selected randomly, glucosylated Hemoglobin (HbA1c), frequency of 
hypoglycemia, frequency of hyperglycemia, body weight and number of hospital admissions were evaluated at 
baseline and after 6 months in both groups. In addition, the children answered the Ped QOL questionnaire 
Results: there is a significant difference between both groups at the onset of the study and after six months 
(p=0.0001) regarding mean glycelated hemoglobin with no difference in body weight. Also there was significant 
difference between the both groups after six months of the study to all subscales and total scores of all diabetic 
modules of PedQOl except communication subscale. Conclusions: CSII is effective in improving the glycemic 
control with no difference in metabolic control and a significant difference in the associated complication with 
time in type 1 diabetic Saudi children than using multiple daily insulin injection. Also the results expressed 
better quality of life among diabetic children using CSII than those using MDI. Recommendation: we 
recommend the implementation of this mode of intensive insulin therapy in all diabetic Saudi children.  
Keywords: continuous subcutaneous insulin infusion, multiple daily insulin injection, type 1      diabetes, quality 
of life. 
 
1. Introduction 
Type 1diabetes is one of the most common chronic diseases in childhood with 480,000 children estimated 
affected globally. The incidence is increasing at 3% per year and annually 76,000 children aged less than 15 
years old develop Type 1 Diabetes worldwide(International diabetes federation 2011). TYPE 1 Diabetes Mellitus 
is the most frequent endocrinology disease in children. The chronic course of the disease and life-long 
substitution of insulin- therapy that must be coordinated with the food, physical activity and the results of 
monitoring blood glucose are factors that make life of these children and their families very difficult (Abdul-
Rasoul et al. 2012). 
  
Incidence and prevalence of pediatric diabetes may differ from one country to another; there is clear 
epidemiological evidence that the incidence is high in many Arab countries particularly in the gulf areas which 
have been classified to very high and intermediate category according to the diamonds world health organization 
study classification (WHO 1990 & Abdulla 2005). In Saudi Arabia the prevalence of type one diabetes mellitus 
among children and adolescent is 109.5 per 100,000 which are considered as high prevalence in2008 ( Al- 
Herbish et al. 2008), On the other hand, recent reports have documented higher incidence rates of T1DM in 
children as 27.5/100,000 per year in specific region, which was differ from one region to another ( Abduljabbar  
et al. 2010). But now the prevalence of DM is hospital based. The statistical department in Prince Abde alrhman 
Alsedery in Sakaka city of Aljouf area at the north of Saudi Arabia revealed that about 1500 pediatric cases 
admitted to hospital from disease complication and blood glucose levels irregularity (Statistical department  
2012).  
 
Multiple daily injection treatment is the most widely used method of insulin administration, and comprises 
intermediate or long acting insulin once or twice a day as a basal dose and rapid-acting insulin at each meal time, 
and patients are required to have at least 3 or more injections a day. A technological alternative to this method of 
insulin delivery is the continuous subcutaneous insulin infusion( Ben-Abas et al. 2005 & Wu et al. 2010 ).A key 
cited advantage of insulin pumps is improving blood glucose levels, as insulin pumps better mimic pancreatic 
insulin delivery and provide a more predictable insulin effect on blood glucose levels than injections. However, 
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there is still a worldwide debate among diabetologists concerning the advantages of continuous subcutaneous 
insulin infusion over multiple daily injections (Churchill et al .2009). 
 
Socio culture's factors can profoundly influence diabetes control among diabetic children. In Saudi Arabia, 
important socioeconomic factors that results from rapid urbanization, excessive consumption of fast food, 
sedentary life style that led to an epidemic of obesity and vitamin D deficiency appear to have negative influence 
on diabetes control (Soliman et al. 2013). The Saudi government in its effort to build the welfare state through 
providing all the health services free of charge, this develop a negative attitude of dependency on the 
government and hospital from parents and their children without taking their role for self monitoring and control 
(Al- Shammari et al.2013). 
 
Quality of life is the degree of well-being felt by an individual or group of people. Unlike standard of living, it is 
not tangible thing, and so cannot be measured directly. It consists of two components; physical and 
psychological. The physical aspect includes; things such as health, diet, and protection against short and long 
term complications. The psychological aspect includes stress, worry, pleasure and other positive or negative 
emotional states (Costanza et al. 2008 & Mohmoud et al. 2013). Monitoring quality of life in clinical practice for 
chronic illness, including diabetes, has been repeatedly advocated. The development and use of pediatric HRQoL 
measures are important for identifying at-risk children and applying early intervention programs (Varni et 
al .2005).  
 
Quality of life for children with diabetes mellitus refers to subjective well-being focuses on the health related 
component of life satisfaction and wellbeing (Kalyva et al .2011). So trained pediatric nurses play a critical role 
in empowering diabetic children to better manage diabetes by using the safest method in insulin delivery for 
these diabetic children and providing them and their families with the required information and consultations as 
well as advantages and disadvantages of insulin administration methods (Peimani et al .2010). 
 
1.2 Significant of the Study: 
Several studies have suggested that intensive therapy with continuous subcutaneous insulin infusion could 
provide better glycemic control, with a lower risk of severe hypoglycemia and a lesser weight gain than multiple 
daily insulin injections, and most of these studied were done in adults ( Skogsberg et al .2008). However a few of 
studies were done on diabetic Saudi children using different method of insulin mode, and how these modes 
affect on children quality of life. So, the present study is conducted to compare between continuous 
subcutaneous insulin infusion and multiple daily insulin injections, assess its effects on quality of life among 
children with type 1 diabetes 
 
1.3 Research Question: 
1- Is there a difference between using CSII and MDI on glycemic, metabolic and adverse effects of disease 
among children 
2- What are the effects of using CSII and MDI on children quality of life 
 
2. Subjects and Methods 
2.1 Design: 
A comparative randomized design was used in this study. 
 
2.2 Setting: 
The study was conducted at maternity and children's hospital in Sakaka city of Aljouf area at the north of Saudi 
Arabia is a tertiary central hospital which has an Endocrine and Diabetes unit.  
 
2.3 Subject: 
50 participants of middle and high school children (ages 12–17 years) with type 1 diabetes who attend a medical 
appointment were selected randomly and divided equally into two groups. One group was using the pump and 
the other group was using MDI. The children were selected if they were Saudi, had been recently used the 
current insulin regimen, were free from any other medical or psychiatric disease diagnosed by physician, and 
willing to participate in the study. The children were interviewed during their follow up clinical visit at the entry 
of the study and after 6 months. 
 
2.4 Tools of data collection: 
Data were collected using the following three tools: 
1-Interview questionnaire that cover the following parts: 
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Part (1): Demographic data that were designed by the researcher and include information about children and 
their families such as age, sex, residence, occupation and educational level. 
 
Part (2): Clinical data obtained from participants’ medical records about disease duration (date of diabetes 
diagnosis), their diabetes regimen, A1C levels and body weight, number of hospitalization and frequency of 
hypo or hyperglycemic attacks as well as presence of technical problems. 
 
2-Pediatric Quality of Life Inventory; Diabetes Module, is a multi-dimensional diabetes-specific instrument that 
assesses children and adolescents (2–18 years). A 5-poin Likert scale ranging from zero to four points; never=4, 
almost never=3, sometimes=2, often=1 and almost always=0.This 28 questions assess 5 scales of HRQOL, 
which include: (1) diabetes symptoms (11 items) (scored 0-44), (2) treatment barriers (4 items)( scored 0-16), (3) 
treatment adherence (7 items)( scored 0-28), (4) worry (3 items)( scored 0-12), and (5) communication (3 
items)( scored 0-12), with total score ranged from 0-112. The lower score indicate better quality of life.  
 
3-Generic Core Scale of ped QOL, a child self-report consisted of 23 items divided into 4 subscales: (1) physical 
function (8 items) (scored 0-32), (2) emotional function (5 items) (scored 0-20), (3) social function (5 items) 
(scored 0-20) and (4) school function (5 items) (scored 0-20), with total score ranged from 0-92. The lower score 
indicate better quality of life.  
 
Both instruments were translated into Arabic and showed good internal consistency reliability and constant 
validity with Cronbach’s alpha value (0.840). 
 
2.5 Methods of data collection: 
Ethical consideration: 
• Official permission from the authorized directors in the selected setting was obtained to conduct the 
study. 
• Children with type 1 diabetes mellitus how fulfill the criteria were invited to participate in the study 
during their regular visits to outpatient clinics. 
• Verbal consent for participation was obtained from children after explaining the aim of the study and 
assuring them that these data will be confidential.  
Pilot study: 
• A pilot study was carried out on 10 children with their mothers to test the feasibility and applicability of 
the tools, and the necessary modification was done.  
• Every child in both groups was interviewed to collect the baseline necessary data, and privacy was 
considered as possible; mothers were asked when indicated.  
• An instructional session was conducted for both groups to maintain ordinary lifestyle activities and to 
adjust insulin dose in relation to glucose level, physical activities, extra meals, illness and other 
significant daily events. The only difference was for children and their families who use pump therapy 
assuring that they were trained well on insulin pump operation and programming and was 
psychologically accepting it and had realistic expectations of CSII. They were instructed to change the 
infusion set every 2-3 days and if there is any sign of insertion site infection. 
• At each visit, the following parameters were registered: body weight, Hemoglobin A1c (HbA1c), 
insulin dosage, number of contacts with the hospital for ketoacidosis (defined as pH, 7.30), severe 
hypoglycemic episodes and cannula insertion site were checked and any technical problems for CSII 
group.  
• All participants completed the Pediatric Quality of Life Inventory, diabetes module and generic Core 
Scale of PedsQL at the beginning of the study as a baseline and after 6 months. 
 
2.6 Statistical analysis:  
The collected data were organized, tabulated and statistically analyzed using SPSS software (Statistical Package 
for the Social Sciences, version 16, SPSS Inc. Chicago, IL, USA). For quantitative data, the range, mean and 
standard deviation were calculated. For qualitative data, comparison between two groups and more was done 
using Chi-square test (χ2) and Fisher Exact test (FE). For comparison between means of both groups, parametric 
analysis (t-test) was used. For comparison between means of two related groups (at onset of the study & after six 
months) of parametric data, paired t-test was used. Significance was adopted at p<0.05. 
 
2.7 Limitation of the study:  
A limitation of this study is the small sample size which may not represent the general population of children 
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with type 1 diabetes mellitus at the study area as most of families prefer taking their children to a large hospital 
or specialized centers at another area. The small sample size also reduced the power of our statistical analyses to 
detect significant differences where they really exist 
 
3. Results: 
Table (1): Basic data of the study diabetic children and their parents (n=50). 
Variables 
The study diabetic children (Type I) 
(n=50) 
  
Group 1 
(n=25) 
Group 2 
(n=25) 
χ2 P 
n % n %   
Age (years):       
12-<15 10 40.0 11 44.0 0.082 0.774 
15-17 15 60.0 14 56.0   
Sex:       
Males 11 44.0 13 52.0 0.321 0.571 
Females 14 56.0 12 48.0   
Residence:       
Rural 11 44.0 11 44.0 0.000 1.000 
Urban 14 56.0 14 56.0   
Family dynamics:       
Both parents 15 60.0 13 52.0 0.325 0.569 
Single parent 10 40.0 12 48.0   
School performance:       
Poor 4 16.0 1 4.0 5.930 0.115 
Average 7 28.0 7 28.0   
Good 8 32.0 15 60.0   
Excellent 6 24.0 2 8.0   
Caregiver education:       
Educated 10 40.0 14 56.0 1.282 0.258 
Non-educated 15 60.0 11 44.0   
Caregiver occupation:       
Working 10 40.0 9 36.0 0.085 0.771 
Housewife 15 60.0 16 64.0   
Disease duration (years):       
1-<4 7 28.0 4 16.0 1.671 0.434 
4-6 8 32.0 12 48.0   
>6 10 40.0 9 36.0   
Group 1: (MDI)      Group 2: (CSII) 
 
Table (1) shows that more than half of diabetic children, 60% in MDI group (G1)  and 56% in CSII group (G2) 
their age were between 15-17 years, 65% of them were females in G(1) while 52% of G(2) were male and 56% 
of both group were from urban areas. Also 60% in group one and 52%in group two had both parents. As regard 
caregivers education and occupation, 60% of them were non-educated and housewife in group one while in 
group two 56%of them were educated and 64% of them were housewife. School performance among group one 
nearly equal with 32%of them had good performance and 40% of them their disease duration more than 6 years, 
while in group two 60% of them had good school performance and 48% of them their disease duration range 
from 4-6 years. 
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Table (2): Mean body weight and HgA1c of the study diabetic children at onset of the study and after six 
months (n=50). 
Variables 
 The study diabetic children (Type I) 
(n=50) 
  
Group 1 
(n=25) 
Group 2 
(n=25) 
χ2 P 
Range 
Mean±SD 
Range 
Mean±SD 
  
Body weight (kg) At onset of 
study 
4.00-80.00 
52.64±17.57 
33.00-78.00 
53.52±14.94 
0.191 0.850 
 After 6 
months of 
the study 
35.00-79.00 
54.20±14.72 
32.00-75.00 
52.60±14.49 
0.387 0.700 
Paired t-test 
P 
 1.084 
0.289 
2.009 
0.056 
  
HgA1c: At onset of 
study 
6.90-8.50 
7.71±0.40 
6.50-7.90 
7.08±0.31 
6.208 0.0001* 
 After 6 
months of 
the study 
6.60-9.70 
7.60±0.61 
6.30-7.70 
6.92±0.32 
4.920 0.0001* 
Paired t-test 
P 
 1.453 
0.159 
4.615 
0.0001* 
  
*Significant (P<0.05) 
Group 1: (MDI)    Group 2 :( CSII) 
 
Table (2) shows that the mean bodyweight of diabetic children treated by multiple daily insulin injections at the 
onset of the study was 52.64±17.57 and after six months increased to 54.20±14.72 with no significant difference 
(p=0.289).While the mean body weight among group two treated by insulin pump at the onset of the study was 
53.52±14.94 and after six months decreased to 52.60±14.49 with no difference between both groups at the onset 
and after six months of the study. Regarding the mean glycelated hemoglobin (HgA1),  it was 7.71±0.40 in 
group one at the onset of the study and decreased to 7.60±0.61 after six months, while in group two the mean 
HgA1 was 7.08±0.31 at the onset of the study and decreased to 6.92±0.32 after six months with a significant 
difference between mean HgA1 among group two at the onset and after six months of the study (p=0.0001).Also 
there was a significant difference between both groups at the onset of the study and after six months (p=0.0001). 
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Table (3): Associated complications among the study diabetic children at onset of the study and after six 
months (n=50). 
Variables 
The study diabetic children (Type I) 
(n=50) 
  
Group 1 
(n=25) 
Group 2 
(n=25) 
χ2 
P 
At onset of 
study 
After 6 
months of 
the study 
At onset of 
study 
After 6 
months of 
the study 
At 
onset 
of 
study 
After 6 
months 
of the 
study 
n %   n %     
No. of hospitalization:           
           
No hospitalization 4 16.0 4 16.0 5 20.0 10 40.0 1.110 8.570 
1-2 14 56.0 15 60.0 14 56.0 15 60.0 0.774 0.014* 
3-4 6 24.0 6 24.0 6 24.0 0 0.0   
5 1 4.0 0 0.0 0 0.0 0 0.0   
χ2 
P 
1.03 
0.793 
7.700 
0.021* 
  
No. of hypoglycemic 
attacks: 
          
No attacks 6 24.0 7 28.0 18 72.0 22 88.0 15.477 19.009 
One 7 28.0 13 52.0 6 24.0 3 12.0 0.001* 0.0001* 
Two 9 36.0 5 20.0 1 4.0 0 0.0   
Three 3 12.0 0 0.0 0 0.0 0 0.0   
χ2 
P 
6.022 
0.111 
2.400 
0.301 
  
No. of hyperglycemic 
attacks: 
          
No attacks 12 48.0 10 40.0 5 20.0 8 32.0 7.660 1.513 
One 11 44.0 14 56.0 11 44.0 17 68.0 0.054 0.469 
Two 2 8.0 1 4.0 7 28.0 0 0.0   
Three 0 0.0 0 0.0 2 8.0 0 0.0   
χ2 
P 
0.880 
0.645 
10.980 
0.012* 
  
*Significant (P<0.05) 
Group 1 :( MDI)   Group 2: (CSII) 
 
As regard the associated complications among the study diabetic children in table (3), it was found that there 
was no significant difference within group (1) treated by multiple daily insulin injection to number of 
hospitalization at the onset and after six months of the study p=0.793.While in group (2) using insulin pump, 
there was a significant difference regarding number of hospital admission at the onset and after six months of the 
study p=0.021. There was also significant difference between both the studied groups regarding the number of 
hospital admission at the onset and after six months of the study (p=0.014). Concerning numbers of 
hypoglycemic attacks, it was noticed that there was no significant difference within group (1) and also within 
group (2) at the onset and after six months of the study. But there was a significant difference between both 
groups at the onset of the study (p=0.001) and after six months of the study (p=0.0001). Regarding number of 
hyperglycemic attacks, there was no significant difference within group (1) at the onset and after six months of 
the study (p=0.645).While there was a significant difference within group (2) regarding number of 
hyperglycemic attacks at the onset and after six months (p=0.012), with no significant differences between both 
studied groups at the onset (p=0.054) and after six months of the study (p=0.469). 
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Table (4): Mean scores of the Pediatric Quality of Life Inventory (Diabetes Module) of the study diabetic 
children (n=50). 
Peds QL Diabetes 
Module main items 
The study diabetic children (Type I) 
(n=50) 
  
Group 1 
(n=25) 
Group 2 
(n=25) 
t-test 
P 
At onset of 
study 
After 6 
months of 
study 
At onset of 
study 
After 6 
months of 
study 
At onset 
of study 
After 6 
months 
of study 
Diabetes symptoms  
 (0-44): 
      
Range 7-37 12-36 6-24 5-19 6.208 6.917 
Mean±SD 23.40±6.86 20.44±6.61 15.84±5.70 10.24±3.27 0.0001* 0.0001* 
Paired t-test 
P 
2.851 
0.009* 
5.509 
0.0001* 
  
Treatment barriers    
(0-16): 
      
Range 4-16 5-16 3-14 3-12 3.317 4.858 
Mean±SD 10.16±3.05 8.72±3.03 7.40±2.83 5.20±1.98 0.002* 0.0001* 
Paired t-test 
P 
4.272 
0.0001* 
5.092 
0.0001* 
  
Treatment adherence  
(0-28): 
      
Range 9-23 2-23 7-22 4-20 2.833 3.961 
Mean±SD 16.08±4.51 13.64±4.57 13.88±3.96 9.20±3.24 0.003* 0.0001* 
Paired t-test 
P 
4.163 
0.0001* 
6.715 
0.0001* 
  
Worry (0-12):       
Range 3-11 1-10 3-11 1-9 3.018 5.770 
Mean±SD 7.76±1.88 7.08±2.12 6.12±1.96 3.84±1.84 0.004* 0.0001* 
Paired t-test 
P 
1.705 
0.101 
7.817 
0.0001* 
  
Communication  
(0-12): 
      
Range 2-10 1-10 1-9 0-7 0.853 1.368 
Mean±SD 5.44±2.16 3.64±2.18 4.88±2.47 2.84±1.95 0.398 0.178 
Paired t-test 
P 
4.700 
0.0001* 
5.696 
0.0001* 
  
Total (0-112)       
Range 30-90 32-83 24-73 15-62 3.667 6.857 
Mean±SD 62.84±14.51 53.52±13.29 48.12±13.8 31.32±9.24 0.001* 0.0001* 
Paired t-test 
P 
5.216 
0.0001* 
7.687 
0.0001* 
  
*Significant (P<0.05) 
Group 1 (MDI)    Group 2 (CSII) 
 
Table (4) shows mean score of Pediatric quality of life (diabetic module items) of the study diabetic children, it 
was noticed that there was a significant difference within group (1) treated by multiple daily insulin injection 
regarding the mean scores of all diabetic module subscale (diabetes symptoms, treatment barriers, treatment 
adherence, communication and the total score) at the onset and after sex month of the study (P<0.05), except 
worry subscale of diabetic module, there was no significant difference. While within group (2) using insulin 
pump there was a significant difference in the mean score of all diabetic module subscale and the total score at 
the onset of the study and after six months(P<0.05). Comparing the mean scores of the PQOL diabetic module at 
the onset and after six months there was significant difference between the both groups at the onset of the study 
to all subscales and total of all diabetic modules except communication subscale. Also there was significant 
difference between the both groups after six months of the study to all subscales and total scores of all diabetic 
modules except communication subscale (P>0.05). 
Journal of Education and Practice                                                                                                                                                      www.iiste.org 
ISSN 2222-1735 (Paper)   ISSN 2222-288X (Online) 
Vol.5, No.31, 2014 
 
83 
Table (5): Mean scores of the generic code scale of Ped QOL of the study diabetic children (n=50). 
Peds QL generic code 
scale  Module main 
items 
The study diabetic children (Type I) 
(n=50) 
  
Group 1 
(n=25) 
Group 2 
(n=25) 
t-test 
P 
At onset of 
study 
After 6 
months of 
study 
At onset of 
study 
After 6 
months of 
study 
At onset 
of study 
After 6 
months 
of study 
Physical health (0-32):       
Range 3-19 3-22 4-19 4-18 2.513 4.057 
Mean±SD 12.36±4.50 11.92±4.86 9.44±3.67 7.24±3.10 0.015* 0.0001* 
Paired t-test 
P 
0.507 
0.617 
3.701 
0.001* 
  
Emotional functioning 
(0-20): 
      
Range 9-20 6-18 4-17 2-17 6.871 5.010 
Mean±SD 15.00±3.24 12.84±3.92 8.92±3.01 7.12±4.15 0.0001* 0.0001* 
Paired t-test 
P 
3.154 
0.004* 
3.464 
0.002* 
  
 Social functioning   
(0-20): 
      
Range 3-14 0-15 3-11 2-12 1.215 3.373 
Mean±SD 8.20±3.32 8.68±4.45 7.24±2.15 5.24±2.49 0.230 0.001* 
Paired t-test 
P 
0.844 
0.407 
4.364 
0.0001* 
  
 School functioning  
(0-20): 
      
Range 5-18 5-20 5-14 2-13 1.736 3.890 
Mean±SD 10.52±3.71 9.76±4.52 9.00±2.33 5.68±2.66 0.089 0.0001* 
Paired t-test 
P 
2.074 
0.049* 
7.093 
0.0001* 
  
Total (0-92)       
Range 23-70 20-67 17-55 13-51 4.072 4.944 
Mean±SD 46.08±11.32 43.20±14.88 34.60±8.41 25.28±10.35 0.0001* 0.0001* 
Paired t-test 
P 
1.609 
0.121 
5.515 
0.0001* 
  
*Significant (P<0.05) 
Group 1 (MDI)     Group 2 (CSII) 
 
As regard the mean score of the generic code scale of the PedOL (a child self report) of the study diabetic 
children in table (5), it was noticed that there was no significant difference within group (1) treated by multiple 
daily insulin injection regarding the mean scores of physical health subscale, social functioning subscale and the 
total mean scores (P>0.05) at the onset and after six months of the study, but there was significant difference 
regarding emotional functioning subscale (p=0.004) and school functioning subscale (p=0.049). While within 
group (2) using insulin pump there was a significant difference in the mean score of all modules subscales and 
the total mean scores at the onset of the study and after six months(P<0.05). Comparing the mean score of the 
PQOL generic code scale at the onset and after six months there was significant difference between both groups 
at the onset of the study to physical health; emotional functioning subscale and total mean scores except social 
functioning and school functioning subscale. As well as there was significant difference between the both groups 
after six months of the study regarding all subscales and total scores of the generic code scale of the PedsQL 
(P<0.05). 
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Table (6): Relationship between Pediatric Quality of Life and basic data of the study diabetic children  
Variables 
Mean scores of Peds QL  
Group 1 
(n=25) 
t-test 
P 
Group 2 
(n=25) 
t-test 
P 
Mean±SD  Mean±SD  
Age (years):     
12-<15 70.60±14.61 2.386 55.00±13.43 2.411 
15-17 57.67±12.34 0.026* 42.71±12.01 0.024* 
Sex:     
Males 71.45±11.24 3.052 48.38±16.57 0.097 
Females 56.07±13.40 0.006* 47.83±10.92 0.923 
Disease duration (years):     
1-<4 72.57±10.45 F-value 53.50±11.47 F-value 
4-6 61.37±15.29 0.705 51.00±15.69 1.536 
>6 57.20±14.01 0.089 41.89±10.28 0.237 
*Significant (P<0.05) 
 
able (6) shows the relationship between Ped QL and basic data of diabetic children, concerning age the mean 
score of Peds Ql in group (1) decreased from 70.60 ±14.61 among children aged 12 to less than 15 years   to 
57.67± 12.34 among children aged 15-17 years which indicate better quality of life with a significant relation 
between quality of life and child age (p= 0.026). Also in group (2) there was improvement in QOl with increased 
age with a positive relation (p=0.024).As regard sex, the mean score ofQOl is better among female in both group 
with a significant relation in group (1) (p=0.006) and no significant relation in group 2 (p=0.923).Regarding 
disease duration the score of QOl decreased with increased disease duration among both group which indicate 
better quality of life with no significant relation in both group. 
 
4. Discussion 
The results of the present study found a decrease in glycelated hemoglobin which achieve glycemic control when 
compare mean HgA1 in group use MDI to group use CSII with no significant difference in group using MDI at 
the onset and after six months of the study, while a significant difference was founded  in mean HgA1 within 
group using CSII at the onset and after six months of the study .The lower HbA1c values during CSII on 
repeated measures were accounted for the lower HbA1c value at the start of the treatment  but there was 
significant difference between modes of therapy in the change over time. (p=0.0001).This results agreed with 
Alhyak et al(2014) we found that when compared diabetic module of QOl with  HbA1c value, positive 
differences were observed in diabetes symptoms, treatment barriers, treatment adherence, worry, communication 
and total HRQoL. Also, regression analysis of the study also showed that HbA1c was the independent 
influencing factor for diabetes symptoms, treatment barriers, and total HRQoL. However these findings 
disagreed with Lawrence et al (2012) who found that youth with poor glycemic control based on their age-
specific hemoglobin A1C target values and those with depressive symptoms had significantly lower PedsQL-
T1DM scores than their counterparts with good control and no or limited depressive symptoms. 
 
Another concern of adolescent who achieve improved glycemic control with intensive therapy of insulin pump is 
weight gain (Sulli & Shashaj (2003). In our study there was no significant difference between mode of insulin 
therapy and body weight at the onset and after six month in both studied group. The most possible explanation 
for the lack of a significant difference in improved metabolic control might be that the study period was too short 
to detect a difference in outcome because many patients could have had adverse effect attacks that might require 
hospital admission. These findings corresponded with Skogsberg et al (2008) who mentioned that the CSII 
treatment group showed significantly greater treatment satisfaction but without any difference in metabolic 
control when compared with MDI treatment during the study period of 24 months. Also Pozzillip et al (2003) 
showed no difference in metabolic control between the CSII and the MDI treatments in a pilot study of patients 
with newly diagnosed type 1diabetes.While Weintrob et al (2003) found a significant interaction between mode 
of therapy and change in BMI , with no change during CSII and a significant, albeit slight, increase during MDI. 
As regard the associated complication among the study diabetic children, the results revealed no significant 
difference within group (1) treated by multiple daily insulin injection regarding number of hospitalization at the 
onset and after six months of the study p=0.793.This lack of difference due to repeated adverse effect of diabetes 
that require hospital admission for interventions. While in group (2) using insulin pump, there was a significant 
difference regarding number of hospital admission at the onset and after six months of the study p=0.021. There 
was also significant difference between both the studied groups regarding the number of hospital admission at 
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the onset and after six months of the study (p=0.014).This may due to children experience with the disease 
particularly with long duration. 
 
The frequency of hypoglycemic attack within group using CSII was obviously lowered than in group using MDI 
with no significance difference within both groups. This might be secondary not only to the different modes of 
therapy but also to the different short-acting insulin used in the 2 treatment modalities. But there was a 
significant difference between both studied groups at the onset (p=0.001) and after six month of study 
(p=0.0001). Many studies have been conducted to compare the efficacy of MDI versus CSII. In a systemic 
review of 22 studies, Jeitler et al (2008) found that CSII resulted in a greater reduction of HbA1c and a reduction 
in hypoglycemic episodes. In a retrospective chart review, Beatajoo et al (2012) & Al saleh et al(2013) found 
that CSII is safe, effective and a superior alternative to MDI. Other studies have shown no difference in the 
glycemic control in these two modalities of treatment. 
 
Regarding number of hyperglycemic attacks, there was no significant difference within group (1) using MDI at 
the onset and after six months of the study (p=0.645).While there was a significant difference within group (2) 
regarding number of hyperglycemic attacks at the onset and after six months (p=0.012). This may because 
noncompliance to treatment regimen and the possible hazards of CSII is the susceptibility of children to the rapid 
development of DKA secondary to pump or infusion-set failure.  With no significant differences between both 
studied groups at the onset (p=0.054) and after six months of the study (p=0.469).study made by Juliusson et al 
(2006) who stated that the most common cause of DKA in children on insulin pump is interruption of insulin 
delivery caused by catheter occlusion, battery failure, depleted insulin supply, patient error or inadequate training. 
The risk of DKA can be minimized by frequent self-monitoring of blood glucose and taking the emergency 
necessary steps in the event of unexplained hyperglycemia. The effectiveness of intensive insulin therapy 
including CSII appears to decrease with a decreased frequency of blood glucose self-monitoring and insulin dose 
adjustment. 
 
Significant positive differences were found in all domains and total of the QoL( diabetic module) within group (1) 
treated by multiple daily insulin injection at the onset and after sex month of the study , except worry subscale 
there was no significant difference. This may explained that adolescent more concerned about his body image 
changed and the long term complication of the chronic disease. Also families of children with poor metabolic 
control had high burden and much worries than those with good control .While within group (2) using insulin 
pump there was a significant positive difference in all diabetic module subscale and the total score at the onset of 
the study and after six months. Previous study made by Valenzuela et al (2006) reported that the insulin pump 
gives patients more flexibility in the timing of their meals and children on the pump can adjust for snacks and 
meals, as well as for exercise and physical exertion. As well as the insulin pump reduces the occurrence of 
serious hypoglycemic episodes. Also significant positive differences were found in all domains and total of the 
QoL (diabetic module) between both groups except communication subscale, this may due to absence of 
afternoon clinics appointment for follow up and Arabian culture restriction and beliefs about chronic disease like 
diabetes .Hanberger et al (20009 ) stated that the score for the MDI group was expected as a baseline finding for 
children on long-term MDI treatment, whereas the CSII group had a significantly higher score. The patients 
using CSII were more satisfied with their treatment option and therefore were likely to find diabetes less difficult 
to manage. It can be expected that these patients will have fewer worries about their disease and that there will 
be a reduced negative impact of diabetes in daily life. Also Al- Hayek et al (2014) found that when compared to 
MDI significant positive differences were found in all domains of the HRQoL of insulin pump users except 
communication. 
 
Comparing the mean score of the PQOL generic code scale between both groups, there was significant 
difference to all subscale and total mean scores except social and school functioning subscale, there was no 
significant difference at the onset of the study. This results disagreed with Kalyva  et al (2011)who illustrated 
that  cultural and social factors associated with support from extended family might at least partly have helped 
these children to cope socially within and, subsequently outside their family. Another results made by De Wit 
(2007) revealed that The school functioning of children and adolescents withT1DM is impaired as well partly 
because of many absences from school  and that poorly controlled diabetes is associated with subtle 
neuropsychological deficits that may reduce academic achievement. As well as children and adolescents with 
T1DM did not report compromise social HRQoL. But after six months there was significant difference to all 
subscale and total mean scores. This may due to the use of injectable devices (pens, pumps), and more flexible 
school schedules accommodating diabetes management may help children and adolescents to adapt to their 
condition and socialize with minimal intervention. A study made by Al-Akour et al (2010) indicated that 
frequent absence from school and the subtle neurophysiologic changes associated with poor glycemic control 
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was overcome in some places by having afternoon clinics and frequent educational sessions. Also Al-Hyak et al 
(2014) reported that PedsQL 3.0 DM when compared with those receiving MDI, insulin pump adolescents had 
significantly higher levels for all domains. 
 
The age of the child was an important predictor of level of QoL , the results indicated better quality of life with a 
significant relation with increase child age in both studied group which corresponded with Chaplin et al ( 2009 ) 
who indicate that as children got older the scores of QOl improved. This could be explained by the fact that 
adolescents manage their disease more subjectively and independently than younger children. These results 
disagreed with Lawrence(2012) &Abdul-Rasoul et al (2013 ) the PedsQL-T1DM total score was negatively and 
significantly associated with younger age. 
 
As regard gender the present study reported better QOl among girls than boys, it has been suggested that the 
differences in QOL score between males and females during adolescence are due to the social context of and 
internal expectations of gender identity. This findings is contradicted with the previous researches (Nansel et al 
2008) that indicated that male gender predicted better QoL than girls as girls have been shown to have more 
diabetes-related worries and take responsibility for their disease earlier because they tend to enter puberty and 
mature earlier than boys .While Al-Yaarubi et al (2014) did not find a relationship between gender and QoL. 
Also s study made by Al-Hayek et al (2014) found insignificant but lower HRQoL among females on the 
PedsQL 3.0 DM subscale of diabetes symptoms, treatment barriers, treatment adherence, and worry than their 
male counterparts. However, compared with male a significant difference was found in female gender on the 
subscale of communication. This lower level of HRQoL in females may be due to culture, as males have easier 
access to medical treatment than females. 
 
Also the results indicated that the quality of life is better with prolonged disease duration among both children 
using multiple daily insulin injection and children using insulin pump. This finding also disagreed with Abdul-
Rasoul et al (2013) who mentioned that early onset and longer duration of diabetes were associated with poorer 
QoL, which is consistent with earlier reports illustrated that longer duration of diabetes was associated with more 
psychological and behavioral problems and worse QoL. Al-hyak et al(2014) found that when compared with 
adolescents with a shorter duration of T1DM, significant negative differences were observed in the PedsQL 3.0 
DM subscales of diabetes symptoms and communication of longer duration on T1DM adolescents. However, in 
the regression analysis, there were no significant differences between HRQoL and diabetes duration of T1DM 
(Verma et al 2010). 
 
5. Conclusion 
The present showed that CSII is effective in improving the glycemic control with no difference in metabolic 
control and a significant difference in the associated complication with time in type 1 diabetic Saudi children 
than using multiple daily insulin injection. Also the results expressed better quality of life among diabetic 
children using CSII than those using MDI  that motivate the implementation of this mode of intensive insulin 
therapy in all diabetic Saudi children.  
 
6. Recommendations 
-Diabetes education must not be given once to the diabetic children and their families, but must be regular follow 
up programs to be applied in fixed times monthly. 
-Assessment of QoL after diagnosis of T1DM should be a routine practice in patients with diabetes to facilitate 
communication, identify early problems and implement early intervention. 
-Conducting more prospective researches to emphasize the factors affecting quality of life of diabetic children 
and adolescents and how to deal with it for developing and refining interventions to ensure their QOL. 
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